↑ Rising
Business
Beyond statins, one drug lowered heart attack risk by 20%
A PCSK9 inhibitor trims heart‑attack risk by 20 % in routine practice
Repatha
2 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Repatha
This hub groups 2 separate news trends connected to Repatha, spanning August 5, 2026 through November 6, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 19 article observations and 18 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 holds ✗
Amgen drops ph. 1 obesity drug, upping pressure on MariTide
Amgen's decision to drop an obesity drug in phase 1 trials has intensified competition in the pharmaceutical sector.